Combination of Ranibizumab and Targeted Laser Photocoagulation

Summary

Intravitreal injections of Ranibizumab will be applied in all patients according to treatment guidelines. The experimental group will receive additional targeted laser photocoagulation of the peripheral areas of capillary non-perfusion (up to 4 laser treatments within 1st year of the study). Based on the long-term observation after CoRaLa I study an importantly shorter duration of treatment and a relevant reduction of the total number of re-injections in RL patients is expected.

Timeline

Start

2020-08-25

Primary completion

2027-11-30

Completion

2027-11-30

Drugs

Indications